Bottom line
What is PHSTX's expense ratio?
PHSTX's expense ratio is 1.04%, or about $104 a year on every $10,000 invested. That is more expensive than 56% of health care sector funds we track (median 0.96%). This share class also charges a front-end sales load of up to 5.75%, taken from your investment when you buy. Its expense ratio includes a 0.25% 12b-1 marketing fee.
Updated Dec 23, 2025
PHSTX fee table
| Net expense ratio | 1.04% |
|---|---|
| Gross expense ratio | 1.04% |
| Management fee | 0.6% |
| 12b-1 (distribution) fee | 0.25% |
| Other expenses | 0.19% |
| Max front-end sales load | 5.75% |
| Max deferred sales charge | 1% |
Source: Fund prospectus fee table, filed Dec 23, 2025
What PHSTX costs in dollars
The SEC requires every fund to show what a $10,000 investment would cost, assuming 5% annual returns and that you sell at the end of each period:
| 1 year | 3 years | 5 years | 10 years | |
|---|---|---|---|---|
| PHSTX | $675 | $887 | $1,116 | $1,772 |
Source: Fund prospectus expense example
The long-run cost of fees
On $100,000 growing at 6% a year for 20 years, a 1.04% expense ratio costs roughly $57,400 in lost growth, versus about $53,400 for the median health care sector fund (0.96%).
Cheaper alternatives to PHSTX
These funds have a similar portfolio (by top-holdings overlap) and a lower expense ratio. Savings are per $10,000 invested.
*Difference in ending value of $10,000 after 20 years at a 6% gross annual return, net of each fund's expense ratio.